IPD.AX

Healthcare Medical Devices

ImpediMed Limited

A$0.01

+0.00 +50.00% today

Price History

Not enough data

Key Stats

Market Cap

21.97M

Avg Volume

6.05M

EPS

-A$0.01

52W High

A$0.06

52W Low

A$0.00

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-3.24

P/B Ratio

2.00

P/S Ratio

1.50

EV/EBITDA

-1.10

EV/Revenue

1.59

Margins

Gross Margin 87.4%

Operating Margin (146.2%)

Net Margin (170.4%)

EBITDA Margin (144.6%)

Growth & Returns

Revenue Growth (YoY)

5.7%

Return on Equity

(162.4%)

Return on Assets

(34.8%)

Liquidity & Leverage

Current Ratio

3.81

Quick Ratio

3.23

Debt / Equity

1.63

Total Cash

15.29M

Total Debt

16.60M

About

ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally. The company offers SOZO Digital Health Platform which transforms fluid status and tissue composition into insights with a single scan; L-Dex Analysis for Lymphedema, designed for early lymphedema detection; BodyComp Analysis; Segmental BodyComp Analysis; and HF-Dex Analysis for Heart Failure. It also provides Lymphedema Prevention Program; and BodyComp Analysis for survivorship health. The company specializes in cancer survivorship, heart health management, medical weight management, wellness, and research. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California.